These results demonstrated that antigen and Cho-CpG can be delivered together into LNs by sHDL to trigger prolonged Ag presentation and cross-priming of T cells, and then robust and long-lived antigen-specific CD8α+ CTL responses were activated with regression of the tumor. The gene discussed is CD8A; the disease is neoplasm.